- Home
- QNCX vs BRFH Comparison
QNCX vs BRFH Comparison
Compare QNCX & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- BRFH
- Stock Information
- Founded
- QNCX 2012
- BRFH 2005
- Country
- QNCX United States
- BRFH United States
- Employees
- QNCX N/A
- BRFH N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- BRFH Packaged Foods
- Sector
- QNCX Health Care
- BRFH Consumer Staples
- Exchange
- QNCX Nasdaq
- BRFH Nasdaq
- Market Cap
- QNCX 47.7M
- BRFH 47.3M
- IPO Year
- QNCX 2019
- BRFH N/A
- Fundamental
- Price
- QNCX $1.59
- BRFH $2.98
- Analyst Decision
- QNCX Strong Buy
- BRFH Strong Buy
- Analyst Count
- QNCX 5
- BRFH 1
- Target Price
- QNCX $8.00
- BRFH $4.50
- AVG Volume (30 Days)
- QNCX 353.3K
- BRFH 6.3K
- Earning Date
- QNCX 08-12-2025
- BRFH 08-13-2025
- Dividend Yield
- QNCX N/A
- BRFH N/A
- EPS Growth
- QNCX N/A
- BRFH N/A
- EPS
- QNCX N/A
- BRFH N/A
- Revenue
- QNCX N/A
- BRFH $10,818,000.00
- Revenue This Year
- QNCX N/A
- BRFH $42.31
- Revenue Next Year
- QNCX N/A
- BRFH $40.92
- P/E Ratio
- QNCX N/A
- BRFH N/A
- Revenue Growth
- QNCX N/A
- BRFH 22.03
- 52 Week Low
- QNCX $0.51
- BRFH $1.81
- 52 Week High
- QNCX $2.45
- BRFH $4.61
- Technical
- Relative Strength Index (RSI)
- QNCX 64.95
- BRFH 51.83
- Support Level
- QNCX $1.48
- BRFH $2.90
- Resistance Level
- QNCX $1.68
- BRFH $2.97
- Average True Range (ATR)
- QNCX 0.14
- BRFH 0.27
- MACD
- QNCX 0.02
- BRFH 0.02
- Stochastic Oscillator
- QNCX 85.71
- BRFH 43.17
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About BRFH Barfresh Food Group Inc.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.